DC Field | Value | Language |
---|---|---|
dc.contributor.author | C Wang | - |
dc.contributor.author | S H Yoon | - |
dc.contributor.author | A A Shah | - |
dc.contributor.author | Y R Chung | - |
dc.contributor.author | J Y Kim | - |
dc.contributor.author | Eui Sung Choi | - |
dc.contributor.author | J D Keasling | - |
dc.contributor.author | S W Kim | - |
dc.date.accessioned | 2017-04-19T09:19:45Z | - |
dc.date.available | 2017-04-19T09:19:45Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0006-3592 | - |
dc.identifier.uri | 10.1002/bit.22831 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/9745 | - |
dc.description.abstract | Farnesol (FOH) production has been carried out in metabolically engineered Escherichia coli. FOH is formed through the depyrophosphorylation of farnesyl pyrophosphate (FPP), which is synthesized from isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) by FPP synthase. In order to increase FPP synthesis, E. coli was metabolically engineered to overexpress ispA and to utilize the foreign mevalonate (MVA) pathway for the efficient synthesis of IPP and DMAPP. Two-phase culture using a decane overlay of the culture broth was applied to reduce volatile loss of FOH produced during culture and to extract FOH from the culture broth. A FOH production of 135.5 mg/L was obtained from the recombinant E. coli harboring the pTispA and pSNA plasmids for ispA overexpression and MVA pathway utilization, respectively. It is interesting to observe that a large amount of FOH could be produced from E. coli without FOH synthase by the augmentation of FPP synthesis. Introduction of the exogenous MVA pathway enabled the dramatic production of FOH by E. coli while no detectable FOH production was observed in the endogenous MEP pathway-only control. | - |
dc.publisher | Wiley | - |
dc.title | Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway = 대장균에서 외래 메발론산 경로를 통한 farnesol의 생산 | - |
dc.title.alternative | Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway | - |
dc.type | Article | - |
dc.citation.title | Biotechnology and Bioengineering | - |
dc.citation.number | 3 | - |
dc.citation.endPage | 429 | - |
dc.citation.startPage | 421 | - |
dc.citation.volume | 107 | - |
dc.contributor.affiliatedAuthor | Eui Sung Choi | - |
dc.contributor.alternativeName | 왕종롱 | - |
dc.contributor.alternativeName | 윤상활 | - |
dc.contributor.alternativeName | Shah | - |
dc.contributor.alternativeName | 정영련 | - |
dc.contributor.alternativeName | 김재연 | - |
dc.contributor.alternativeName | 최의성 | - |
dc.contributor.alternativeName | Keasling | - |
dc.contributor.alternativeName | 김선원 | - |
dc.identifier.bibliographicCitation | Biotechnology and Bioengineering, vol. 107, no. 3, pp. 421-429 | - |
dc.identifier.doi | 10.1002/bit.22831 | - |
dc.subject.keyword | farnesol | - |
dc.subject.keyword | mevalonate pathway | - |
dc.subject.keyword | FPP synthase | - |
dc.subject.keyword | phosphatase | - |
dc.subject.keyword | E. coli | - |
dc.subject.local | Farnesol | - |
dc.subject.local | farnesol | - |
dc.subject.local | Mevalonate pathway | - |
dc.subject.local | mevalonate pathway | - |
dc.subject.local | Mevalonate Pathway | - |
dc.subject.local | FPP synthase | - |
dc.subject.local | Phosphatases | - |
dc.subject.local | phosphatase | - |
dc.subject.local | Phosphatase | - |
dc.subject.local | Escherichia coli. | - |
dc.subject.local | escherichia coli | - |
dc.subject.local | Escherichia Coli | - |
dc.subject.local | Escherichia coli | - |
dc.subject.local | E.coli | - |
dc.subject.local | escherichia coil | - |
dc.subject.local | E. coli | - |
dc.subject.local | E. Coli | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.